Suchergebnisse - "Shim, Ju H"

PubPharm (2)

1

Is ageing a problematic hurdle to the efficacy of first-line atezolizumab plus bevacizumab in hepatocellular carcinoma?

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von An, J. | Shim, J.

CommentOn: Liver Int. 2022 Nov;42(11):2538-2547. - PMID 35986902

2

Is ageing a problematic hurdle to the efficacy of first‐line atezolizumab plus bevacizumab in hepatocellular carcinoma?

enthalten in: Liver International | 2022

von An, J. | Shim, J.

1
[1]